SCHEMBL322440

SCHEMBL322440

CC(C)(C)Oc1ccc(C(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
KMT2A Q03164 1/20 0.53
TSHR P16473 3/20 0.53
HSD17B10 Q99714 2/20 0.53
ALDH1A1 P00352 2/20 0.53
TP53 P04637 2/20 0.52
NR4A2 P43354 1/20 0.49
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
SRD5A2 P31213 3/20 0.48
PARP15 Q460N3 1/20 0.48
PARP10 Q53GL7 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
FABP2 P12104 1/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
SLC22A12 Q96S37 1/20 0.47
PKM P14618 1/20 0.47
FAAH O00519 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6891189 0.94 HSD17B10 (0.59) CA1CA2KMT2ATSHRHSD17B10
SCHEMBL29385898 0.87 CA1 (0.59) CA1CA2KMT2ATSHRHSD17B10
SCHEMBL3018669 0.86 RARB (0.54) CA1CA2KMT2ATSHRHSD17B10
Benzoic Acid SCHEMBL27552887 0.85 CA1 (0.50) CA1CA2KMT2ATSHRHSD17B10
SCHEMBL27867240 0.85 CA1 (0.57) CA1CA2KMT2ATSHRHSD17B10
SCHEMBL20076975 0.84 ELANE (0.60) KMT2ATSHRALDH1A1SRD5A2SMN1; SMN2
SCHEMBL5718737 0.83 CA1 (0.55) CA1CA2KMT2ATSHRHSD17B10
SCHEMBL8733203 0.83 CA1 (0.55) CA1CA2KMT2ATSHRHSD17B10
SCHEMBL28050269 0.83 TSHR (0.59) CA1CA2KMT2ATSHRHSD17B10
SCHEMBL27717363 0.83 CA1 (0.55) CA1CA2KMT2ATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279630-B1 DEVELOPER FOR LIGHT-SENSITIVE LITHOGRAPHIC PRINTING PLATE CAPABLE OF PROCESSING COMMONLY THE NEGATIVE-TYPE AND THE POSITIVE TYPE AND DEVELOPER COMPOSITION FOR LIGHT-SENSITIVE MATERIAL KONICA CORPORATION (JP) 1993-10-13 EP claimed
EP-0279630-A1 Developer for light-sensitive lithographic printing plate capable of processing commonly the negative-type and the positive type and developer composition for light-sensitive material KONICA CORPORATION (JP) 1988-08-24 EP claimed
CN-121586750-A Composition for forming silicon-containing underlayer film for directional self-assembly 日产化学株式会社 2026-02-27 CN disclosed
US-20250367166-A1 NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE SCRIPPS RESEARCH INST (US) 2025-12-04 US disclosed
US-12275693-B2 Onium salt, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-15 US disclosed
WO-2025041813-A1 COMPOSITION FOR FORMING SILICON-CONTAINING UNDERLAYER FILM FOR INDUCED SELF-ASSEMBLY 日産化学株式会社 2025-02-27 WO disclosed
CN-111936471-B Non-fused thiophene derivatives and uses thereof 埃尼奥制药公司 2024-10-29 CN disclosed
US-20240302744-A1 COMPOSITION FOR FORMING SILICON-CONTAINING UNDERLAYER FILM FOR INDUCED SELF-ORGANIZATION NISSAN CHEMICAL CORPORATION (JP) 2024-09-12 US disclosed
CN-117063129-A Composition for forming silicon-containing underlayer film for directional self-assembly 日产化学株式会社 2023-11-14 CN disclosed
WO-2023212650-A1 NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE THE SCRIPPS RESEARCH INSTITUTE (US) 2023-11-02 WO disclosed
US-11774853-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-03 US disclosed
EP-0279630-B1 DEVELOPER FOR LIGHT-SENSITIVE LITHOGRAPHIC PRINTING PLATE CAPABLE OF PROCESSING COMMONLY THE NEGATIVE-TYPE AND THE POSITIVE TYPE AND DEVELOPER COMPOSITION FOR LIGHT-SENSITIVE MATERIAL KONICA CORPORATION (JP) 1993-10-13 EP disclosed
EP-0507576-A1 Polypropylene-based resin compositions TOSOH CORPORATION (JP) 1992-10-07 EP disclosed
US-5106724-A High speed, odorless KONICA CORPORATION (JP) 1992-04-21 US disclosed
US-4699698-A Preparation of benzoic acid ortho-esters and novel compounds of this type BASF AKTIENGESELLSCHAFT (DE) 1987-10-13 US disclosed
US-4699698-A Preparation of benzoic acid ortho-esters and novel compounds of this type BASF AKTIENGESELLSCHAFT (DE) 1987-10-13 US disclosed
US-4304715-A Enkephalin analogues HUDSON DEREK 1981-12-08 US disclosed
US-RE30731-E Enkephalin analogues Hudson, Derek (GB) 1981-09-01 US disclosed
US-4198398-A Enkephalin analogues HUDSON DEREK (GB) 1980-04-15 US disclosed
US-4009208-A N,N'-HEPTAMETHYLENEBIS(4-METHOXYBENZAMIDE) STERLING DRUG INC. (US) 1977-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12275693-B2 Onium salt, chemically amplified resist composition and patterning process PAG1, SLC6A5, LBR CA1 1236/4885CA2 162/4885KMT2A 1890/4885
US-20250367166-A1 NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE TLR1, TLR4, TLR3 CA1 2685/4885CA2 2636/4885KMT2A 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.